Impact of Pretreatment Interstitial Lung Disease on Radiation Pneumonitis and Survival After Stereotactic Body Radiation Therapy for Lung Cancer

Journal of Thoracic Oncology - United States
doi 10.1097/jto.0000000000000359
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Impact of Pretreatment Interstitial Lung Disease on Radiation Pneumonitis and Survival in Patients Treated With Lung Stereotactic Body Radiation Therapy (SBRT)

International Journal of Radiation Oncology Biology Physics
OncologyRadiologyCancer ResearchRadiationNuclear MedicineImaging
2016English

Pretreatment Factors Influencing Radiation Pneumonitis After Stereotactic Body Radiation Therapy in the Treatment of Lung Cancer

International Journal of Radiation Oncology Biology Physics
OncologyRadiologyCancer ResearchRadiationNuclear MedicineImaging
2017English

Pretreatment Factors Influencing Radiation Pneumonitis After Stereotactic Body Radiation Therapy in the Treatment of Lung Cancer

Cureus
2020English

Dose–Volume Metrics Associated With Radiation Pneumonitis After Stereotactic Body Radiation Therapy for Lung Cancer

International Journal of Radiation Oncology Biology Physics
OncologyRadiologyCancer ResearchRadiationNuclear MedicineImaging
2012English

Lung Stereotactic Body Radiation Therapy (SBRT) Impact on Lung Aeration

International Journal of Radiation Oncology Biology Physics
OncologyRadiologyCancer ResearchRadiationNuclear MedicineImaging
2019English

Case Series of 23 Patients Who Developed Fatal Radiation Pneumonitis After Stereotactic Body Radiotherapy for Lung Cancer

Technology in Cancer Research and Treatment
MedicineCancer ResearchOncology
2018English

PS03.03 Salvage Therapy for Relapse After Stereotactic Body Radiation for Stage I Lung Cancer

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2017English

Rib Dose Constraints for Lung Stereotactic Body Radiation Therapy

International Journal of Radiation Oncology Biology Physics
OncologyRadiologyCancer ResearchRadiationNuclear MedicineImaging
2016English

Pretreatment 18f-Fluorodeoxyglucose Uptake in the Lung Parenchyma Predicts Poor Survival After Stereotactic Body Radiation Therapy in Patients With Stage I Non-Small Cell Lung Cancer

Technology in Cancer Research and Treatment
MedicineCancer ResearchOncology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy